Stay updated with breaking news from Neurologic Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease therapeutics,...
Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics,...
The histopathologic alteration caused by SARS‑CoV‑2 on mammalian neurological systems.
Quince Therapeutics, Inc. , a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that the U.S. Food...
Well-capitalized into 2026 with ability to fully fund lead asset EryDex expected through Phase 3 trial under special protocol assessment and to NDA submission EryDex utilizes autologous...